Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2013) 33 P4 | DOI: 10.1530/endoabs.33.P4

BSPED2013 Poster Presentations (1) (89 abstracts)

Subnormal Synacthen testing in infants <6 months age: a review of diagnoses and outcomes

Timothy Shao Ern Tan 1 , Rajesh Chidanandaswamy 2 , Fiona Ivison 3 , Mars Skae 2 , Raja Padidela 2 , Sarah Ehtisham 2 , Peter Clayton 4 , Indi Banerjee 2 & Leena Patel 2


1Manchester Medical School, The University of Manchester, Manchester, UK; 2Department of Paediatric Endocrinology, Royal Manchester Children’s Hospital, Manchester, UK; 3Department of Clincal Biochemistry, Royal Manchester Children’s Hospital, Manchester, UK; 4Faculty of Human and Medical Sciences, The University of Manchester, Manchester, UK.


Background: The standard dose Synacthen test (SDST) is commonly used to identify glucocorticoid deficiency. A subnormal SDST in young infants raises the possibility of adrenal insufficiency (AI) due to pathology such as congenital adrenal hyperplasia (CAH). A physiological delay in maturation of adrenal glucocorticoid secretion may be another explanation especially in asymptomatic infants with a transiently subnormal SDST.

Aims: To review the diagnoses and outcomes of infants <6 months who had a subnormal SDST at a single regional centre.

Methods: Data from 45 infants <6 months age who had a SDST over a 2-year period was reviewed. A SDST with cortisol level <550 nmol/l at 30 min was defined as subnormal. Hyponatraemia and requirement for fludrocortisone indicated salt wasting AI. Clinical outcomes were reviewed at 6 months after presentation.

Results: The SDST was normal in 23 (51%) and subnormal in 22 (49%) (15 males) infants. Among the latter, the subnormal SDST was associated with hypopituitarism (3/22), 21-hydroxylase CAH (1/22), salt-wasting primary AI of unknown aetiology (1/22), persistent glucocorticoid deficiency necessitating replacement with hydrocortisone but aetiology not identified (9/22, 41%) and transiently impaired SDST (8/22, 36%). Of the eight infants with a transient abnormality, two were born small-for-gestational-age, three were premature and none received steroid treatment antenatally. Their median (range) 30 min cortisol at initial SDST was 416 (266; 431) nmol/l which normalised by age 4 (1; 9) months. They were asymptomatic until follow-up SDST results normalized. No infant presented with an adrenal crisis.

Conclusion: A significant proportion of infants <6 months age have persistent AI, the aetiology of which can be primary, secondary or unascertained. A third of infants are asymptomatic and have a transiently subnormal SDST. This is suggestive of a physiological delay in maturation of adrenal glucocorticoid secretion.

Volume 33

41st Meeting of the British Society for Paediatric Endocrinology and Diabetes

British Society for Paediatric Endocrinology and Diabetes 

Browse other volumes

Article tools

My recent searches

No recent searches.